
No. of Pages: 96 | Report Code: BMIRE00029267 | Category: Life Sciences
No. of Pages: 96 | Report Code: BMIRE00029267 | Category: Life Sciences
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Glioma Treatment Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Government Funding for Glioma Treatment
4.1.2 Increase in Prevalence of High-Grade Glioma
4.2 Key Market Restraints
4.2.1 High Cost of Diagnosis
4.3 Key Market Opportunities
4.3.1 Advancements in Healthcare Sector in Emerging Economies
4.4 Future Trends
4.4.1 Surge in Drug Approvals for Glioma Treatment
4.5 Impact Analysis:
5. Glioma Treatment Market - Europe Market Analysis
5.1 Europe Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
6. Europe Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease
6.1 Overview
6.2 Europe Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
6.3 Astrocytoma
6.3.1 Overview
6.3.2 Astrocytoma: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Oligoastrocytoma
6.4.1 Overview
6.4.2 Oligoastrocytoma: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Oligodendroglioma
6.5.1 Overview
6.5.2 Oligodendroglioma: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type
7.1 Overview
7.2 Europe Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Surgery
7.3.1 Overview
7.3.2 Surgery: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Chemotherapy
7.4.1 Overview
7.4.2 Chemotherapy: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Radiation Therapy
7.5.1 Overview
7.5.2 Radiation Therapy: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade
8.1 Overview
8.2 Europe Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
8.3 Low Grade
8.3.1 Overview
8.3.2 Low Grade: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Grade I: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Grade II: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 High Grade
8.4.1 Overview
8.4.2 High Grade: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Grade III: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.2 Grade IV: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Glioma Treatment Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Europe Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospital & Clinics
9.3.1 Overview
9.3.2 Hospital & Clinics: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Glioma Treatment Market - Country Analysis
10.1 Overview
10.1.1 Europe Glioma Treatment Market, by Country
10.1.1.1 UK
10.1.1.1.1 UK: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 UK: Europe Glioma Treatment Market, by Disease
10.1.1.1.3 UK: Europe Glioma Treatment Market, by Treatment Type
10.1.1.1.4 UK: Europe Glioma Treatment Market, by Grade
10.1.1.1.4.1 UK: Europe Glioma Treatment Market, by Low Grade
10.1.1.1.4.2 UK: Europe Glioma Treatment Market, by High Grade
10.1.1.1.5 UK: Europe Glioma Treatment Market, by End User
10.1.1.2 Germany
10.1.1.2.1 Germany: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Germany: Europe Glioma Treatment Market, by Disease
10.1.1.2.3 Germany: Europe Glioma Treatment Market, by Treatment Type
10.1.1.2.4 Germany: Europe Glioma Treatment Market, by Grade
10.1.1.2.4.1 Germany: Europe Glioma Treatment Market, by Low Grade
10.1.1.2.4.2 Germany: Europe Glioma Treatment Market, by High Grade
10.1.1.2.5 Germany: Europe Glioma Treatment Market, by End User
10.1.1.3 France
10.1.1.3.1 France: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 France: Europe Glioma Treatment Market, by Disease
10.1.1.3.3 France: Europe Glioma Treatment Market, by Treatment Type
10.1.1.3.4 France: Europe Glioma Treatment Market, by Grade
10.1.1.3.4.1 France: Europe Glioma Treatment Market, by Low Grade
10.1.1.3.4.2 France: Europe Glioma Treatment Market, by High Grade
10.1.1.3.5 France: Europe Glioma Treatment Market, by End User
10.1.1.4 Italy
10.1.1.4.1 Italy: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 Italy: Europe Glioma Treatment Market, by Disease
10.1.1.4.3 Italy: Europe Glioma Treatment Market, by Treatment Type
10.1.1.4.4 Italy: Europe Glioma Treatment Market, by Grade
10.1.1.4.4.1 Italy: Europe Glioma Treatment Market, by Low Grade
10.1.1.4.4.2 Italy: Europe Glioma Treatment Market, by High Grade
10.1.1.4.5 Italy: Europe Glioma Treatment Market, by End User
10.1.1.5 Spain
10.1.1.5.1 Spain: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.2 Spain: Europe Glioma Treatment Market, by Disease
10.1.1.5.3 Spain: Europe Glioma Treatment Market, by Treatment Type
10.1.1.5.4 Spain: Europe Glioma Treatment Market, by Grade
10.1.1.5.4.1 Spain: Europe Glioma Treatment Market, by Low Grade
10.1.1.5.4.2 Spain: Europe Glioma Treatment Market, by High Grade
10.1.1.5.5 Spain: Europe Glioma Treatment Market, by End User
10.1.1.6 Rest of Europe
10.1.1.6.1 Rest of Europe: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.2 Rest of Europe: Europe Glioma Treatment Market, by Disease
10.1.1.6.3 Rest of Europe: Europe Glioma Treatment Market, by Treatment Type
10.1.1.6.4 Rest of Europe: Europe Glioma Treatment Market, by Grade
10.1.1.6.4.1 Rest of Europe: Europe Glioma Treatment Market, by Low Grade
10.1.1.6.4.2 Rest of Europe: Europe Glioma Treatment Market, by High Grade
10.1.1.6.5 Rest of Europe: Europe Glioma Treatment Market, by End User
11. Europe Glioma Treatment Market Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sun Pharmaceutical Industries Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Amgen Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Teva Pharmaceutical Industries Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Amneal Pharmaceuticals Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Karyopharm Therapeutics Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Biocon Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. Europe Glioma Treatment Market Segmentation
Table 2. UK: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 3. UK: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 4. UK: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 5. UK: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 6. UK: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 7. UK: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 8. Germany: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 9. Germany: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 10. Germany: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 11. Germany: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 12. Germany: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 13. Germany: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. France: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 15. France: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 16. France: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 17. France: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 18. France: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 19. France: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 20. Italy: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 21. Italy: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 22. Italy: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 23. Italy: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 24. Italy: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 25. Italy: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 26. Spain: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 27. Spain: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 28. Spain: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 29. Spain: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 30. Spain: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 31. Spain: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 32. Rest of Europe: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 33. Rest of Europe: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 34. Rest of Europe: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 35. Rest of Europe: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 36. Rest of Europe: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 37. Rest of Europe: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 38. Organic Developments Done By Companies
Table 39. Inorganic Developments Done By Companies
Table 40. Glossary of Terms, Europe glioma treatment market
List of Figures
Figure 1. Europe Glioma Treatment Market Segmentation, By Country
Figure 2. Europe Glioma Treatment Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Europe Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 6. Astrocytoma: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Oligodendroglioma: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Oligodendroglioma: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 10. Surgery: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chemotherapy: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Radiation Therapy: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Europe Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 15. Low Grade: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Grade I: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Grade II: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. High Grade: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade III: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Grade IV: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Europe Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Hospital & Clinics: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: Europe Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe Glioma Treatment Market, By Country, 2022 ($Mn)
Figure 25. Europe Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 26. UK: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Germany: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. France: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Italy: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Spain: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Rest of Europe: Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Growth Strategies Done by the Companies in the Market, (%)
1. Amgen Inc
2. Amneal Pharmaceuticals Inc
3. Biocon Ltd
4. F. Hoffmann-La Roche Ltd
5. Karyopharm Therapeutics Inc
6. Merck & Co Inc
7. Pfizer Inc
8. Sun Pharmaceutical Industries Ltd
9. Teva Pharmaceutical Industries Ltd